[TIMI risk score validation for patients with acute coronary syndrome without ST elevation]

Area of Science:

• Cardiology
• Internal Medicine
• Clinical Research

Background:

• Non-ST elevation acute coronary syndromes (NSTE-ACS) are a significant cause of hospitalizations, contributing to 10-15% of annual infarcts or deaths.
• Effective risk stratification is crucial for managing NSTE-ACS patients and optimizing treatment strategies.

Purpose of the Study:

• To evaluate the 6-month cardiovascular event rates in patients hospitalized for NSTE-ACS.
• To validate the predictive accuracy of the Thrombolysis in Myocardial Infarction (TIMI) risk score in this patient cohort.

Main Methods:

• A retrospective analysis of 204 patients admitted with NSTE-ACS.
• Telephone follow-up at 6 months to assess combined endpoints: death, re-admission for acute coronary syndrome, and revascularization.
• Application of the TIMI risk score for risk stratification.

Main Results:

• The study included 204 patients (70.2% male, mean age 64.5 years).
• TIMI risk score distribution: 25.5% low risk, 52% intermediate risk, 22.5% high risk.
• A significant, progressive increase in combined cardiovascular events was observed with increasing TIMI risk scores (p < 0.001).

Conclusions:

• The TIMI risk score demonstrated good correlation with subsequent cardiovascular events at 6 months in the studied NSTE-ACS population.
• Intermediate and high TIMI risk scores are associated with a higher likelihood of adverse cardiovascular events.
• The findings support the utility of the TIMI risk score for risk stratification and management decisions in NSTE-ACS patients.